Biosolution Co.Ltd (086820) — Capital Reinvestment Ratio
Biosolution Co.Ltd (086820) has a Capital Reinvestment Ratio of 1.27x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩17.41 Million) in capital expenditures (₩22.15 Million). Check Biosolution Co.Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Biosolution Co.Ltd Capital Reinvestment Ratio (2018–2023)
This chart tracks Biosolution Co.Ltd's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see Biosolution Co.Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Biosolution Co.Ltd (2018–2023)
Year-by-year Capital Reinvestment Ratio for Biosolution Co.Ltd from 2018 to 2023. See Biosolution Co.Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.54x | ₩2.16 Billion | ₩1.16 Billion | ▼ -93.3% |
| 2021 | 7.96x | ₩83.29 Million | ₩663.15 Million | ▲ +1054.8% |
| 2018 | 0.69x | ₩1.03 Billion | ₩707.50 Million | — |